FDA needs data on new Gardasil use

Merck hit another snag in its efforts to expand the market for its blockbuster cervical cancer vaccine Gardasil. The FDA told the company it wants additional data before deciding whether to approve its use in women ages 27 to 45. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.